Effects of latex avoidance on latex sensitization, atopy and allergic diseases in patients with spina bifida

K Blumchen1, P Bayer, D Buck

  • 1Department of Pediatric Pneumology and Immunology, Charité University Medicine, Berlin, Germany. nina.bluemchen@charite.de

Allergy
|July 28, 2010
PubMed

Insights

Implementing latex-free protocols in children with spina bifida significantly reduced latex sensitization and allergy. This proactive approach also appears to prevent other allergic conditions by limiting allergen sensitization spread.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Immunology
  • Spina Bifida Management

Background:

  • Latex-free protocols were introduced for children with spina bifida a decade ago.
  • These measures have coincided with a decrease in latex sensitization and allergy within this at-risk population.

Purpose of the Study:

  • To assess the impact of primary latex-free prophylaxis on allergic diseases.
  • To evaluate atopy as an indicator of sensitization spread in pediatric spina bifida patients.

Main Methods:

  • Examined 120 children with spina bifida (current group) operated under latex-free conditions.
  • Assessed latex sensitization, latex allergy, aero- and food allergen sensitization, and allergic diseases.
  • Compared results to a historical group (n=87) and a general population sample (n=12,403).

Main Results:

  • Significantly lower rates of latex sensitization (5% vs 55%) and latex allergy (0.8% vs 37%) in the current group compared to the historic group.
  • Reduced sensitization to aeroallergens (20.8% vs 41.4%) and allergic diseases (15% vs 35%) in the current group.
  • Prevalence of atopy, sensitization, and allergic diseases in the current group mirrored that of the general population.

Conclusions:

  • Latex avoidance in spina bifida patients effectively prevents latex sensitization and allergy.
  • This strategy also appears to inhibit sensitization to other allergens and reduce allergic diseases.
  • Prevention of sensitization spreading is a likely mechanism behind these broader protective effects.
Abstract

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...